ALKS 2680 Improves Wakefulness in Narcolepsy Type 2 and IH : vimarsana.com

ALKS 2680 Improves Wakefulness in Narcolepsy Type 2 and IH

Alkermes plc announced positive results from a phase 1b study evaluating ALKS 2680 for treating narcolepsy type 2 and idiopathic hypersomnia.

Related Keywords

, Ron Grunstein , Alkermes , Woolcock Institute Of Medical Research , Wakefulness Test , Woolcock Institute , Medical Research ,

© 2024 Vimarsana